Clover Health Investments (CLOV) Technical analysis
Healthcare
Market data as of 2026-09-04 · Autonium metric computed 2026-09-04 · model v1CLOV technical analysis — the short answer
CLOV is classified Range with a 14-day RSI of 47.5, three-month return of +11.1% and 20-day realised volatility of 42.8%. Autonium's composite Algo Score currently reads 18/100.
Price versus moving averages
Last close4.26
20-day4.29-0.8%
50-day4.51-5.7%
100-day4.03+5.5%
200-day3.14+35.5%
Trend classificationRange
Returns
1 week+0.6%
1 month-8.7%
3 months+11.1%
6 months+112.8%
12 months+58.2%
Volatility and drawdown
Realised volatility (20d, annualised)+42.8%
Realised volatility (60d, annualised)+55.8%
1-year volatility percentile19
Current drawdown from peak-21.3%
Deepest 1-year drawdown-55.5%
SPY volatility (20d)+8.1%
Autonium Algo Score
Current score18 / 100
7-day change-9
30-day change-45
90-day change-75
1-year range11 – 95
Readings above 7028
Readings below 3028
Signal drivers
MomentumNegative
Technical trendNegative
VolatilityNeutral
SentimentNeutral
CLOV's Algo Score fell 9 points over the last seven days. The factors currently reading positive are none; reading negative: momentum, technical trend.
Sector peers — 3-month return
LLY — Eli Lilly and Co.1.6
UNH — UnitedHealth Group-0.6
JNJ — Johnson & Johnson18.2
ABBV — AbbVie Inc.12.9
MRK — Merck & Co.24.5
Bullish signals
- Price above the 200-day average
- +6.7% three-month excess return vs SPY
Neutral signals
- RSI mid-range at 47.5
- Volatility in the 19th percentile of its own year
- Contracting volume regime
Bearish signals
- Price below the 50-day average
Score history
- 2026-09-0718
- 2026-09-0418
- 2026-09-0335
- 2026-09-0231
- 2026-09-0137
- 2026-08-3127
- 2026-08-2824
- 2026-08-2725
- 2026-08-2625
- 2026-08-2524
- 2026-08-2421
- 2026-08-2117
Track CLOV inside Autonium
Full factor detail, alerts when the score changes, and Toni to ask why.
Continue analysing CLOV
Autonium publishes research, not recommendations. Scores, factors and written reads describe historical and current data and are not buy or sell advice. Not financial advice. Market data is refreshed on a schedule and may lag. See our methodology and disclosures.